Skip to main content
. 2011 Dec 15;106(3):460–467. doi: 10.1038/bjc.2011.557

Table 2. Population pharmacokinetics parameters of Pt estimated from the final model and bootstrap validation (500 resamplings).

    Bootstrap analysis
 
Parameter Original data set estimate (%RSE) Mean 95% CI Shrinkage (%)
Structural model        
IPV (l) 3.10 (3.1) 3.11 2.94 to 3.26  
         
IPCL (l h–1)= θ1+ θ2 x EPI
 θ1 4.66 (4.3) 4.66 4.34 to 5.02  
 θ2 –0.531 (6.9) –0.533 –0.471 to –0.586  
CL (l h–1) 9.63 (5.2) 9.61 8.77 to 10.49  
         
V (l) = θ3+ θ4 x EPI
 θ3 21.4 (5.9) 21.40 19.40 to 24.49  
 θ4 0.805 (26.3) 0.778 0.472 to 1.188  
k23 (h−1) 0.632 (3.7) 0.635 0.595 to 0.678  
k32 (h−1) 0.0425 (4.4) 0.0424 0.0395 to 0.0450  
Vmax (mg l–1) 0.0123 (9.2) 0.0124 0.0106 to 0.0142  
KM (mg l–1) 2.00 (10.1) 1.98 1.66 to 2.37  
kB (l h–1) 0.382 (7.2) 0.381 0.330 to 0.437  
         
Interindividual variability
IIVIPV (%CV) 19.7 (25.9) 19.1 14.9 to 23.2 9.7
IIVIPCL (%CV) 22.3 (19.0) 21.9 17.9 to 25.3 11.0
IIVCL(%CV) 39.4 (28.2) 38.0 30.1 to 47.3 9.1
IIVV (%CV) 26.4 (42.5) 26.5 17.0 to 38.1 6.8
IIVBmax (%CV) 51.3 (12.2) 50.8 44.6 to 56.9 0.7
ρ V/Vmax –0.124 (29.3) –0.123 –0.062 to –0.197  
         
Residual errors
ε1 (%CV) 17.8 (9.6) 17.7 16.4 to 19.2 7.3
ε2 (mg l–1) 0.098 (7.0) 0.098 0.083 to 0.114  

Abbreviations: θ=value of the parameter associated with the equation of the covariate; ε1=exponential part of the residual error; ε2=additive part of the residual error; CI=confidence interval; %CV=percentage of coefficient of variation; CL=clearance associated with the serum (central) compartment; IPCL=IP clearance; IIV=interindividual variability; Pt=platinum; %RSE=relative standard error; V and IPV=volume of distribution associated with the serum central and IP compartments; Vmax and KM=the Michaelis–Menten constants used to model covalent binding to protein; kB=the elimination constant rate of Pt-bound Pt to protein; k23, k32=rate constants between central and peripheral compartments.